The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of GM, Appointment of Joint Broker and TVR

26 Mar 2020 11:50

RNS Number : 7317H
Location Sciences Group PLC
26 March 2020
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

26 March 2020

Location Sciences Group plc

("Location Sciences" or the "Company")

 

Result of General Meeting

Appointment of Joint Broker

and

Total Voting Rights

Result of Meeting

Location Sciences (AIM: LSAI), the leading location data verification company, announces that all Resolutions put to Shareholders at the General Meeting held earlier today were duly passed.

Accordingly, a re-organisation of the Company's share capital will occur with effect from close of business today comprising a sub-division of the Existing Ordinary Shares to create two classes of shares: New Ordinary Shares with a nominal value of 0.1 pence and New Deferred Shares with a nominal value of 0.9 pence.

The proportion of the issued ordinary share capital of the Company held by each Shareholder immediately before and after the Sub-division will remain unchanged. All entitlements under outstanding share options shall be recalculated accordingly as a result of the Sub-division.

Following the Sub-division, the ISIN code for the New Ordinary Shares will remain GB00BGT36S19 and the SEDOL code for the New Ordinary Shares will remain BGT36S1.

In addition, application has been made for, in aggregate, 114,858,571 New Ordinary Shares to be admitted to trading on AIM immediately following the Sub-division comprising; 111,430,000 Placing Shares, 1,142,857 Broker Shares and 2,285,714 Settlement Shares. Admission is expected to occur at 8.00 am on 27 March 2020. 

As announced earlier today, certificates in relation to the Warrants will be posted to Placees by no later than 10 Business Days after Admission.

Appointment of Joint Broker

Peterhouse Capital Limited will be appointed as joint broker to the Company immediately following Admission.

Total Voting Rights

Following Admission, the Company will have 491,510,305 Ordinary Shares in issue admitted to trading on AIM. This figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

This announcement should be read in conjunction with the full text of the Circular which was posted to Shareholders on 9 March 2020, copies of which are available on the Company's website at www.locationsciencesgroup.ai. Capitalised terms in this announcement have the same meaning as given in the Circular.

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

For further information please contact:

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

David Rae, Chief Financial Officer

 

 

Shore Capital (Nomad and Broker)

 

Tel: +44 (0)20 7408 4090

Tom Griffiths

David Coaten

 

Peterhouse Capital

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

Jessica Ballinger

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

About Location Sciences

Location Sciences is the pre-eminent global location verification provider to the $190 billion digital advertising industry, working in partnership with brands, media agencies and suppliers to reduce ad wastage and improve the effectiveness of location-based advertising campaigns.

The digital advertising marketplace remains unregulated and unmonitored, with an estimated $19 billion wasted on ad fraud in 2018. Location Sciences has developed Verify, the world's first independent location verification product. Utilising sophisticated machine learning and pattern recognition technologies, Verify detects location ad fraud and shines a light on location data inaccuracy with the aim of bringing back integrity, transparency and trust to the market place.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCBBGDXRSDDGGL
Date   Source Headline
18th Sep 20177:00 amRNSHalf-year Report and Trading Update
14th Sep 20176:03 pmRNSTR-1: Notification of major holdings
13th Sep 201712:40 pmRNSTR-1: Notification of major holdings
11th Sep 20177:00 amRNSLaunch of Location Sciences
6th Sep 20174:59 pmRNSTR-1: Notification of major holdings
5th Sep 20172:49 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNew Directorship
25th Aug 20171:31 pmRNSTR-1: Notification of major holdings
24th Aug 20171:17 pmRNSTR-1: Notification of major holdings
10th Aug 20177:00 amRNSSettlement of credit facility and loan note
9th Aug 20173:00 pmRNSTR-1: Notification of major holdings
28th Jul 20173:43 pmRNSTR-1: Notification of major holdings
27th Jul 20174:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
24th Jul 201711:54 amRNSResult of AGM and GM
24th Jul 20177:01 amRNSAGM Statement
24th Jul 20177:00 amRNSResult of Open Offer
17th Jul 20177:00 amRNSProxama signs agreement with Rail Delivery Group
13th Jul 20177:00 amRNSContract Renewal
3rd Jul 20176:01 pmRNSHolding(s) in Company
30th Jun 201711:31 amRNSResult of Placing
30th Jun 20177:01 amRNSProposed Placing
30th Jun 20177:00 amRNSFinal Results
25th May 20177:00 amRNSNew Contracts
18th May 20177:00 amRNSBoard Changes
17th May 20177:00 amRNSConclusion of the Strategic Review
27th Apr 20171:07 pmRNSNotification of Interest In Shares
28th Mar 20172:04 pmRNSIssue of Equity and Total Voting Rights
7th Mar 20177:00 amRNSDirector Declaration
1st Mar 20174:39 pmRNSResult of General Meeting
1st Mar 20177:00 amRNSNew Contract Win
16th Feb 20177:00 amRNSAppointment of Non-Executive Chairman
13th Feb 20177:00 amRNSPosting of Circular and Notice of General Meeting
9th Feb 20173:40 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Contract Win
3rd Feb 20177:00 amRNSIssue of Equity
23rd Jan 20177:00 amRNSNew Partnership
10th Jan 20177:00 amRNSBeacon network expansion
5th Jan 201710:20 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing
21st Dec 20167:00 amRNSNew Contract
13th Dec 20167:00 amRNSTrading and Funding update
25th Nov 20167:00 amRNS'Santa Forgot' campaign for Alzheimer's Research
29th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20162:55 pmRNSHolding(s) in Company
22nd Sep 20165:22 pmRNSExercise of Options
22nd Sep 20167:00 amRNSNew Contract
2nd Sep 20167:00 amRNSGoogle Certification
11th Aug 20163:24 pmRNSTR-1 Notification of Major Interest in Shares
11th Aug 20163:20 pmRNSDirector/PDMR Shareholding
27th Jul 20164:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.